Prevention of Stroke and Sudden Cardiac Death by Recording of 1-Channel Electrocardiograms
NCT ID: NCT04637230
Last Updated: 2022-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
10000 participants
OBSERVATIONAL
2021-10-01
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Echocardiography-based Motion Integration and Management for Substrate Characterization and STAR Therapy in Ventricular Tachycardias
NCT05964660
Evaluating the Accuracy and Practical Utility of AI-Enhanced 12-Lead ECG
NCT07316231
Identification of Arrhythmias With One-time ECG
NCT03753139
AF Stroke Substudy SL-ECG Versus 12lead ECG
NCT03715361
Evaluation of Long-term Incidence of Ventricular Arrhythmias in Patients With Acute Myocarditis
NCT04264455
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In PRICE phase 2, ECG diagnosis by the AI will be compared with the diagnosis by 3 general cardiologists of the same ECGs. It is expected that the AI will surpass the general cardiologists in terms of diagnostic accuracy.
The final clinical phase of the PRICE project will comprise a randomized controlled community trial of risk patients to establish the superiority in stroke prevention of AI detection of AF on smart-watch ECGs vs. no AF detection.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sinus Rhythm
Subjects/patients in normal sinus rhythm
Electrocardiogram analysis by Artificial Intelligence
1-channel electrocardiograms are collected to train an Artificial Intelligence in the automatic diagnosis of regular and irregular heart rhythms
Atrial Fibrillation
Patients with atrial fibrillation
Electrocardiogram analysis by Artificial Intelligence
1-channel electrocardiograms are collected to train an Artificial Intelligence in the automatic diagnosis of regular and irregular heart rhythms
Atrial Premature Complexes
Patients with atrial premature complexes in between sinus beats
Electrocardiogram analysis by Artificial Intelligence
1-channel electrocardiograms are collected to train an Artificial Intelligence in the automatic diagnosis of regular and irregular heart rhythms
Ventricular Premature Complexes
Patients with ventricular premature complexes in between sinus beats
Electrocardiogram analysis by Artificial Intelligence
1-channel electrocardiograms are collected to train an Artificial Intelligence in the automatic diagnosis of regular and irregular heart rhythms
Ventricular Tachycardia, Nonsustained
Patients with episodes of nonsustained ventricular tachycardia in between sinus beats
Electrocardiogram analysis by Artificial Intelligence
1-channel electrocardiograms are collected to train an Artificial Intelligence in the automatic diagnosis of regular and irregular heart rhythms
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electrocardiogram analysis by Artificial Intelligence
1-channel electrocardiograms are collected to train an Artificial Intelligence in the automatic diagnosis of regular and irregular heart rhythms
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
A-Rhythmik GmbH
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karl-Heinz Kuck, MD
Role: PRINCIPAL_INVESTIGATOR
Universitäres Herzzentrum, Lübeck, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitäres Herzzentrum, Lübeck, Germany
Lübeck, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-139
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.